Gerlach Jörg C, Mutig Kerim, Sauer Igor M, Schrade Petra, Efimova Ekaterina, Mieder Tim, Naumann Götz, Grunwald Andreas, Pless Gesine, Mas Antoni, Bachmann Sebastian, Neuhaus Peter, Zeilinger Katrin
Department of Surgery, Charité, Campus Virchow, Humboldt University, Berlin, Germany.
Transplantation. 2003 Sep 15;76(5):781-6. doi: 10.1097/01.TP.0000083319.36931.32.
The development of a bioreactor providing a three-dimensional network of interwoven capillary membranes with integrated oxygenation and decentralized mass exchange enables the culture of primary human liver cells from discarded donor organs for extracorporeal liver support.
Primary liver cells were isolated from 54 discarded organs (donor age 56.7+/-13.2 years). Between 2.8x10(10) and 6.4x10(10) parenchymal cells (PC) were cocultured with nonparenchymal cells (NPC) of the same organ in bioreactors (n=36). The metabolic activity of the cells was regularly determined during culture. The cell morphology and ultrastructure were investigated after culture periods of 1 to 5 weeks.
Cell metabolism was maintained over at least 3 weeks after a phase of adaptation lasting 2 to 3 days. Through the use of transmission electron microscopy and immunohistochemistry, it was demonstrated that PC and NPC spontaneously formed tissue-like structures. Vascular cavities (CD 31 immunoreactivity [IR]) and bile duct-like channels (CK 19 IR), both exhibiting proliferation activity (Ki-67 IR), were regularly distributed. Some of the bile duct-like channels showed similarities to the Canals of Hering found in the natural liver. Cells expressing morphologic and antigenic characteristics of adult liver stem cells (CD 34 IR and c-kit IR) and areas with cells that showed both hepatocyte and biliary characteristics were detected.
The results show that primary human liver cells obtained from discarded donor organs recover and can be maintained in bioreactors for clinical liver support therapy. In addition, initial observations on adult liver stem-cell culture in bioreactors are presented.
一种生物反应器的开发,其提供具有集成氧合和分散质量交换的三维交织毛细血管膜网络,使得能够从废弃供体器官中培养原代人肝细胞用于体外肝脏支持。
从54个废弃器官(供体年龄56.7±13.2岁)中分离原代肝细胞。将2.8×10¹⁰至6.4×10¹⁰个实质细胞(PC)与同一器官的非实质细胞(NPC)在生物反应器中共培养(n = 36)。在培养期间定期测定细胞的代谢活性。在培养1至5周后研究细胞形态和超微结构。
在持续2至3天的适应期后,细胞代谢至少维持3周。通过透射电子显微镜和免疫组织化学的使用,证明PC和NPC自发形成组织样结构。血管腔(CD 31免疫反应性[IR])和胆管样通道(CK 19 IR)均表现出增殖活性(Ki-67 IR),且分布规律。一些胆管样通道与天然肝脏中的赫林管相似。检测到表达成人肝干细胞形态和抗原特征的细胞(CD 34 IR和c-kit IR)以及具有肝细胞和胆管特征的细胞区域。
结果表明,从废弃供体器官获得的原代人肝细胞能够恢复,并可在生物反应器中维持用于临床肝脏支持治疗。此外,还展示了在生物反应器中成人肝干细胞培养的初步观察结果。